Myasthenia Gravis: The Rationale of Present Day Therapy

letter

. 1952 Nov;44(6):426–434.

Myasthenia Gravis

The Rationale of Present Day Therapy

PMCID: PMC2617138 PMID: 13000420

These references are in PubMed. This may not be the complete list of references from this article.

MILLIKAN C. H., EATON L. M. Cortisone in neurologic diseases. Proc Staff Meet Mayo Clin. 1950 Aug 16;25(17):499–500. [PubMed] [Google Scholar]
PERRY S. M. Diabetes mellitus in association with myasthenia gravis. J Am Med Assoc. 1950 Aug 12;143(15):1332–1333. doi: 10.1001/jama.1950.82910500012007a. [DOI] [PubMed] [Google Scholar]
SEYBOLD W. D., McDONALD J. R., CLAGETT O. R., GOOD C. A. Tumors of the thymus. J Thorac Surg. 1950 Aug;20(2):195–215. [PubMed] [Google Scholar]
STEPHENS F. I. Paralysis due to reduced serum potassium concentration during treatment of diabetic acidosis; report of case treated with 33 grams of potassium chloride intravenously. Ann Intern Med. 1949 Jun;30(6):1272–1286. doi: 10.7326/0003-4819-30-6-1272. [DOI] [PubMed] [Google Scholar]
TUYNMAN P. E., WILHELM S. K. Potassium deficiency associated with diabetic acidosis. Ann Intern Med. 1948 Aug;29(2):356–361. doi: 10.7326/0003-4819-29-2-356. [DOI] [PubMed] [Google Scholar]